Neuradiab Uses, Dosage, Side Effects and more
Neuradiab is under investigation in clinical trial NCT00615186 (Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody Therapy).
| Trade Name | Neuradiab |
| Generic | Neuradiab |
| Neuradiab Other Names | 81c6, a murine igg2 anti-tenascin monoclonal antibody labeled with iodine 131 (I-131), Anti-tenascin monoclonal antibody 81c6-I-131, Iodine i 131 moab 81c6, Iodine i 131 monoclonal antibody 81c6, Iodine I-131 monoclonal antibody 81c6, Moab, 81c6, murine, iodine-I-131 radiolabeled, to human glioma, Neuradiab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
